Cosmo Pharmaceuticals Archives - Medical Design Sourcing

Medtronic, Cosmo Pharma expand AI collab for GI Genius

Medtronic’s GI Genius intelligent endoscopy module [Image courtesy of Medtronic]Medtronic (NYSE: MDT) + announced today that it agreed to expand its partnership with Cosmo Intelligent Medical Devices.

The medtech giant aims to build upon already realized achievements with the Cosmo Pharmaceuticals subsidiary. Their AI-driven partnership centers around the GI Genius intelligent endoscopy module.

Through the exclusive, global partnership, Medtronic and Cosmo seek to revolutionize endoscopy by utilizing AI to improve patient outcomes. Medtronic said in a news release that the alliance reinforces its position in AI-integrated healthcare. The company also says it represents a “significant leap” in incorporating AI into endoscopic care.

Medtronic and Cosmo partnered on innovative and scalable AI platforms like the AI Access kit. AI Access hosts multiple third-party AI applications to allow for faster innovati…

Medtronic turns to third-party developers to boost GI Genius’ AI

The GI Genius module’s AI-based enhancements include green boxes that highlight areas that may need extra scrutiny during a colonoscopy. [Image courtesy of Medtronic]

Medtronic has turned to Nvidia to enable an AI Access platform to boost the GI Genius intelligent endoscopy module’s capabilities.

Think of a software-based business model — an app marketplace — where third-party developers create new AI tools to boost early colorectal cancer detection during colonoscopies. It’s a type of product development strategy that may become more common among medical device companies, especially as they shift toward more innovation in the digital space.

The world’s largest medtech company points to GI Genius as the first FDA-cleared, AI-assisted colonoscopy tool that helps physicians detect polyps leading to colorectal cancer. Cosmo Pharmaceuticals, GI Genius’s developer and manufactur…

AI-aided colon cancer tech gets FDA nod

Cosmo Pharmaceuticals announced today that it received marketing authorization for its GI Genius AI-based lesion detecting system.

GI Genius is an intelligent endoscopy system that uses AI/machine learning to detect lesions in the colon such as polyps or suspected tumors in real-time during a colonoscopy, according to a news release.

The device, which received FDA approval through the de novo pathway, is compatible with all endoscopes. Cosmo is the sole manufacturer, while Medtronic is the exclusive worldwide distributor.

Made up of hardware and software designed to highlight portions of the colon, the device uses AI algorithms to identify regions of interest where it may detect a potential lesion. GI Genius generates markers, which appear as green squares and are accompanied by a short, low-volume sound. It superimposes them on the video from the endoscope camera when a potential lesion is identified.

The device’s signals alert a clinician …